gp41 inhibitors (Locus)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namegp41 inhibitors (Locus)
Drug Alias NameHIV fusion inhibitors (Locus)antiviral agents (Locus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransmembrane glycoprotein gp41 inhibitors
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsVirus DiseasesHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLocus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLocus
Active IndicationsN/A
Inactive IndicationsVirus DiseasesHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A